Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.

@article{Mohamad2019RiskOS,
  title={Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.},
  author={Osama Mohamad and Takahiro Tabuchi and Yuki Nitta and Akihiro Nomoto and Akira Sato and Goro Kasuya and Hirokazu Makishima and Hak Choy and Shigeru Yamada and Toshitaka Morishima and Hiroshi Tsuji and Isao Miyashiro and Tadashi Kamada},
  journal={The Lancet. Oncology},
  year={2019},
  volume={20 5},
  pages={
          674-685
        }
}
Carbon ion radiotherapy for bladder cancer: A case report
TLDR
CIRT may allow for avoiding resection and was well tolerated with curative outcomes in a 76-year-old patient with bladder cancer who had serious comorbidities and could not tolerate surgery or chemotherapy.
Predicted Secondary Malignancies following Proton versus Photon Radiation for Oropharyngeal Cancers
TLDR
Treatment with IMPT can achieve comparable target dose coverage while significantly reducing the dose to healthy organs, which can lead to fewer predicted SMNs compared with IMRT.
Microscopic Review on the Curability and Invasiveness of Heavy Ion Radiotherapy in a Patient with Locally Advanced High-grade Prostate Cancer without Biochemical Recurrence:
An 85-year-old men with a past history of locally advanced and high Gleason grade (4 + 5) prostate cancer died sud-denly. The autopsy confirmed that his direct cause of death was suffocation following
Carbon Ion Therapy: A Modern Review of an Emerging Technology
TLDR
A comprehensive review of the studies of carbon ion radiotherapy for almost every type of malignancy, including intracranial malignancies, head and neck malignANCs, primary and metastatic lung cancers, tumors of the gastrointestinal tract, prostate and genitourinary cancers, sarcomas, cutaneous malIGNancies, breast cancer, gynecologic malignations, and pediatric cancers is provided.
The role of combined ion-beam radiotherapy (CIBRT) with protons and carbon ions in a multimodal treatment strategy of inoperable osteosarcoma.
Carbon ion radiation therapy in breast cancer: a new frontier
TLDR
A comprehensive review describes the physical and biological properties of carbon ion radiation therapy, with an emphasis on how these properties can be applied in the setting of breast cancer.
Secondary cancers after carbon‐ion radiotherapy and photon beam radiotherapy for uterine cervical cancer: A comparative study
TLDR
The incidence of secondary cancers in patients treated with CIRT for cervical cancer and patients who received standard photon radiotherapy (RT) throughout the same period are evaluated.
Cellular Damage in the Target and Out-Of-Field Peripheral Organs during VMAT SBRT Prostate Radiotherapy: An In Vitro Phantom-Based Study
TLDR
The results show that radiation doses in the location of the intestine and lung resulted in significantly higher radiation doses than the further locations, and a strong, multiparametric radiobiological response of the cells in the prostate.
Risk of Secondary Malignancies in Patients with prostate cancer: A Systematic Review and Meta-analysis
TLDR
The overall risk of SMs in patients with prostate cancer is not significantly different from general population, and even in patients undergoing prostatectomy or brachytherapy, the risk is lower, but the incidence of some cancers such as melanoma, bladder, and urinary tract appears to be higher than the public in all types of treatment approaches.
Modelling neoplastic cell transformation and tumour induction for charged particles with the local effect model
TLDR
The methods established in this work provide a foundation for quantitatively describing carcinogenesis related effects after particle radiation and for optimizing treatment strategies based on individual patient plans with regard to secondary cancer risk.
...
...

References

SHOWING 1-10 OF 33 REFERENCES
Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: from 20 to 16 fractions.
Predicted Secondary Malignancies following Proton versus Photon Radiation for Oropharyngeal Cancers
TLDR
Treatment with IMPT can achieve comparable target dose coverage while significantly reducing the dose to healthy organs, which can lead to fewer predicted SMNs compared with IMRT.
Smoking effect on secondary bladder cancer after external beam radiotherapy for prostate cancer.
TLDR
Findings suggest that smoking history might be one of criteria to choose radical prostatectomy than external beam radiotherapy for prostate cancer, and that age would not be a criterion for therapeutic selection in terms of secondary bladder cancer.
Carbon Ion Therapy: A Modern Review of an Emerging Technology
TLDR
A comprehensive review of the studies of carbon ion radiotherapy for almost every type of malignancy, including intracranial malignancies, head and neck malignANCs, primary and metastatic lung cancers, tumors of the gastrointestinal tract, prostate and genitourinary cancers, sarcomas, cutaneous malIGNancies, breast cancer, gynecologic malignations, and pediatric cancers is provided.
The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984-2000.
  • T. Pickles, N. Phillips
  • Medicine
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • 2002
Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis
TLDR
Radiotherapy for prostate cancer was associated with higher risks of developing second malignancies of the bladder, colon, and rectum compared with patients unexposed to radiotherapy, but the reported absolute rates were low.
A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction.
TLDR
A comprehensive review of dosimetry studies for external-beam treatment modalities including classical radiation therapy, 3D-conformal x-ray therapy, intensity-modulated x-rays therapy (IMRT and tomotherapy) and proton therapy is covered.
...
...